Tweet
UKE Chief Dr. J?rg de Batin: "the situation is very serious"
UPDATE: Uke's head: number of new infections "down significantly"
First good news could announce on Monday the uke's head: the number of new infections with the life-threatening intestinal germ of EHEC is "down significantly". The Chairman of the Board of the University Medical Center Hamburg-Eppendorf (UKE), Prof. J?rg de Batin, on Monday in the city said. The number of patients with the complication of HUS, hemolytic uremic syndrome, is, however, stable.
The Infektiologe Prof. Ansgar Lohse urged that further strictly to observe the hygiene rules. "We recommend to follow the recommendations of the Robert Koch Institute."
How successfully the new active substance is Eculizumab in severe HUS cases, will only say in three to four weeks leave, said the kidney specialist Rolf steel. The UKE will used this "rescue attempt" (steel) in 11 patients.
Total 30 HUS sufferers have no kidney function more as of Batin said on Sunday. "The situation is very serious." The course of the disease is progressive. Whether the new therapy with the antibody Eculizumab strikes, one could not say so far. "The assessment of the impact will take weeks", said de Batin. In the city, at least two people have died from the dangerous pathogens.
"We will lose more people", so de Batin. "We must prepare all of us, that we lose younger people." Ten of the very severely sick patients were treated with the new antibody Eculizumab. The new therapy will be administered only to patients with severe neurological disorders, said de Batin. These disorders include epilepsy similar conditions and the launching of eyesight and speech assets. This must be not only with further deaths, but also with numerous consequential for the survivors. As of Batin is assumed, that a proportion of patients maintain the neurological disorders and the kidneys in the long term no longer work as well.
http://www.microsofttranslator.com/b...-%2Findex.html
UPDATE: Uke's head: number of new infections "down significantly"
First good news could announce on Monday the uke's head: the number of new infections with the life-threatening intestinal germ of EHEC is "down significantly". The Chairman of the Board of the University Medical Center Hamburg-Eppendorf (UKE), Prof. J?rg de Batin, on Monday in the city said. The number of patients with the complication of HUS, hemolytic uremic syndrome, is, however, stable.
The Infektiologe Prof. Ansgar Lohse urged that further strictly to observe the hygiene rules. "We recommend to follow the recommendations of the Robert Koch Institute."
How successfully the new active substance is Eculizumab in severe HUS cases, will only say in three to four weeks leave, said the kidney specialist Rolf steel. The UKE will used this "rescue attempt" (steel) in 11 patients.
No all-clear
The State of HUS patients in the Hamburger University Hospital Eppendorf (UKE) is but nachwievor extremely critical. Of the approximately 80 patients are four children and 14 adults in the intensive care unit. Eight of them were ill severely and would have to be ventilated. The intensive medical fight with serious neurological problems of patients - about States of coma and seizures. Hourly new adult patients would be hospitalized.Total 30 HUS sufferers have no kidney function more as of Batin said on Sunday. "The situation is very serious." The course of the disease is progressive. Whether the new therapy with the antibody Eculizumab strikes, one could not say so far. "The assessment of the impact will take weeks", said de Batin. In the city, at least two people have died from the dangerous pathogens.
"We will lose more people", so de Batin. "We must prepare all of us, that we lose younger people." Ten of the very severely sick patients were treated with the new antibody Eculizumab. The new therapy will be administered only to patients with severe neurological disorders, said de Batin. These disorders include epilepsy similar conditions and the launching of eyesight and speech assets. This must be not only with further deaths, but also with numerous consequential for the survivors. As of Batin is assumed, that a proportion of patients maintain the neurological disorders and the kidneys in the long term no longer work as well.
Blood plasma supplies become scarce
Meanwhile the UKE has further bottlenecks to fight: the blood plasma supplies are scarce and the number of beds is nearly saturated. "It not more than 60 patients can be included in the UKE", said the professor. Keep the seriously ill patients in the UKE, be moved easier HUS sufferers in hospitals in other clinics, to Hanover and L?beck, among others. Meanwhile, the UKE focuses its capacity on HUS patients. "The treatment of the patients is but guaranteed", assured de Batin.http://www.microsofttranslator.com/b...-%2Findex.html
